Schedule 13D ownership disclosure
BEONE MEDICINES LTD SPONSORED ADS
Ordinary shares, par value $0.0001 per share · CUSIP: 07725L102
Event date: 2025-03-03
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- HHLR Advisors, Ltd.Reported CIK 0001762304
Shares: 92,805,741.00 · Class: 6.7%
- Hillhouse Investment Management, Ltd.Reported CIK 0001510589
Shares: 92,805,741.00 · Class: 6.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-25-001327
- Form type
- SCHEDULE 13D/A
- Filer
- BeOne Medicines Ltd.
- CIK
- CIK 1651308
- Filed
- Mar 03, 2025
- Reporting period
- Mar 03, 2025
- Description
- Schedule 13D beneficial ownership